Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations.
Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations. Blood. 2018 06 28; 131(26):2989-2992.